What is AIDDISON?
AIDDISON™ is an innovative drug discovery software that harnesses the capabilities of artificial intelligence (AI), computer-aided drug design (CADD), and machine learning (ML) to offer an essential toolkit for medicinal chemistry. This comprehensive platform seamlessly integrates various facets of virtual screening, encompassing both ligand-based and structure-based design approaches. Additionally, it facilitates advanced techniques for in silico lead optimization and discovery, ensuring that researchers have access to cutting-edge resources for their projects. By streamlining the drug discovery process, AIDDISON™ significantly enhances the efficiency and effectiveness of medicinal chemistry endeavors.
Pricing
Free Trial Offered?:
Yes
Integrations
No integrations listed.
Similar Software to AIDDISON
Stack AI
AI agents are designed to engage with users, answer inquiries, and accomplish tasks by leveraging data and APIs. These intelligent systems can provide responses, condense information, and derive insights from extensive documents. They also facilitate the transfer of styles, formats, tags, and summaries between various documents and data sources. Developer teams utilize Stack AI to streamline customer support, manage document workflows, qualify potential leads, and navigate extensive data libraries. With just one click, users can experiment with various LLM architectures and prompts, allowing for a tailored experience. Additionally, you can gather data, conduct fine-tuning tasks, and create the most suitable LLM tailored for your specific product needs. Our platform hosts your workflows through APIs, ensuring that your users have immediate access to AI capabilities. Furthermore, you can evaluate the fine-tuning services provided by different LLM vendors, helping you make informed decisions about your AI solutions. This flexibility enhances the overall efficiency and effectiveness of integrating AI into diverse applications.
Learn more
QUALO
QUALO is a versatile cloud-based software solution aimed at addressing significant challenges related to data output and visualization within behavioral health, community health, and healthcare sectors. Its main objective is to provide meaningful insights while ensuring that clients, staff, administrators, and funders are not inundated with excessive information.
The platform merges data collection capabilities with tailored evidence-based practice supports, allowing for the accurate gathering of relevant data precisely when needed. Furthermore, it features specialized care coordination tools specifically designed to meet the unique needs of human service providers.
A major advantage of QUALO is its ability to integrate smoothly with various systems, particularly electronic health records (EHRs). By serving as a centralized data entry hub, it aims to mitigate the common shortcomings found in the data output and visualization of EHRs. In addition, QUALO's mobile-optimized interface facilitates access from a variety of devices, thus improving the overall efficiency of the data collection workflow. This adaptability ensures that users can engage with the platform whenever and wherever they need to make informed decisions.
Learn more
SYNTHIA Retrosynthesis Software
SYNTHIA™ Retrosynthesis software, created through the collaboration of computer scientists and chemists, empowers researchers to swiftly explore new and established pathways for target molecules. This tool enables efficient scanning of numerous pathways, helping to pinpoint the most suitable options tailored to specific requirements. With advanced visualization and filtering capabilities, users can uncover the most economical route to synthesize their desired molecule. The platform also allows for the customization of search parameters, enabling the user to either exclude or emphasize particular reactions, reagents, or molecular classes. Additionally, it presents innovative and distinctive synthetic routes to construct the target compound. Users can effortlessly generate a list of commercially available starting materials needed for their synthesis projects. Furthermore, the ISO/IEC 27001 Information Security Certification ensures the utmost confidentiality, integrity, and security of all data processed within the software, providing peace of mind to its users. This commitment to data protection reinforces the software's value in the scientific community.
Learn more
SpliceCore
Utilizing RNA sequencing (RNA-seq) data in conjunction with Artificial Intelligence offers both an essential need and a remarkable opportunity for developing therapies that target splicing errors. By harnessing machine learning techniques, we can identify new splicing errors and promptly create therapeutic compounds to rectify these issues. Our specialized AI platform, SpliceCore, is dedicated to the discovery of RNA-based therapeutics. This advanced technology excels in analyzing RNA sequencing data with exceptional speed and accuracy. It effectively identifies, assesses, and confirms potential drug targets, surpassing conventional methods in efficiency. A key feature of SpliceCore is our proprietary database, which houses over 5 million potential RNA splicing errors, making it the largest resource of its type worldwide and vital for evaluating any RNA sequencing dataset submitted for analysis. The incorporation of scalable cloud computing enables us to manage extensive RNA sequencing data efficiently and economically, thereby accelerating the development of new therapies. This groundbreaking strategy is set to transform the field of RNA therapeutics, paving the way for unprecedented advancements in treatment options. As we move forward, the potential for discovery in this domain continues to expand, promising a future filled with innovative solutions.
Learn more
Screenshots and Video
Company Facts
Company Name:
Merck KGaA
Date Founded:
1668
Company Location:
Germany
Company Website:
www.sigmaaldrich.com/US/en/services/software-and-digital-platforms/aiddison-ai-powered-drug-discovery
Product Details
Deployment
SaaS
Training Options
Documentation Hub
Online Training
Webinars
On-Site Training
Video Library
Support
Standard Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English